Role of Neoadjuvant Targeted Therapies Remains Unclear in NSCLC

By News Health
3 weeks Ago

(MedPage Today) — Use of neoadjuvant or perioperative immunotherapy in combination with chemotherapy has proven effective for some patients with non-small cell lung cancer (NSCLC), but its role in patients with EGFR- or ALK-mutated disease is…

Source link : https://www.medpagetoday.com/spotlight/asco-nsclc/116781

Author :

Publish date : 2025-08-01 14:21:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Perfect posture is a myth

3D-printed electronics can dissolve in water for quick recycling

Risk of Malignant Tumor Rises After Traumatic Brain Injury

Study Examines Off-Target Mortality in Cancer Screening

Low-Cal Mediterranean Diet Plus Exercise Linked to Less Diabetes Onset

We are unlocking how frozen microbes stay alive for 100,000 years